Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Dexcom previews new data for 15-day glucose ... which integrates data from glucose monitors with insulin pumps, after competitor Insulet received an expanded indication in August.

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...